Optimizing laser therapy doses for knee osteoarthritis pain relief
Official title: Optimal High-Intensity Laser Therapy (HILT) Parameters for Pain and Function in Patients With Moderate Knee Osteoarthritis: A Randomized Controlled Trial
Run by Al Hayah University In Cairo · NCT06916676 · Data updated 2026-11-12
This study is testing different doses of laser therapy to see which one helps people aged 45 to 75 with knee osteoarthritis feel less pain and move better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Al Hayah University In Cairo Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | April 23, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | April 8, 2025 |
| Trial ID | NCT06916676 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 45 to 75 with a clinical diagnosis of knee osteoarthritis and moderate pain levels.
✕Probably not a fit
Patients with inflammatory arthritis or those who have had recent knee surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to determine the most effective doses of High-Intensity Laser Therapy (HILT) for alleviating pain and enhancing function in individuals suffering from moderate knee osteoarthritis. Participants aged 45 to 75 will be randomly assigned to receive one of three different doses of HILT or a placebo treatment, administered three times a week over four weeks. The primary outcomes will focus on changes in knee pain levels and functional ability, assessed through a pain scale and a questionnaire. This approach seeks to identify the optimal therapeutic dose for improved patient outcomes.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive treatment option that significantly reduces knee pain and improves function for patients with osteoarthritis.
How similar studies have gone: While there is ongoing research into laser therapies for pain management, this specific dose optimization approach is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age between 45 and 75 years, inclusive. Clinical diagnosis of knee osteoarthritis according to American College of Rheumatology (ACR) criteria (knee pain plus at least 3 of 6: age \>50, morning stiffness \<30 min, crepitus, bony tenderness, bony enlargement, no palpable warmth). Radiographic evidence of knee osteoarthritis corresponding to Kellgren-Lawrence grade II or III in the target knee. Average knee pain intensity ≥ 4 on a 10-cm Visual Analogue Scale (VAS) during weight-bearing activities in the past week. Willingness and ability to attend 3 sessions per week for 4 weeks and attend all assessment sessions. Exclusion Criteria: Previous surgery on the index knee (including arthroscopy within the last year or joint replacement). Diagnosis of inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis, gout). Intra-articular corticosteroid or hyaluronic acid injection in the index knee within the last 3 months. Clinically significant comorbidities that could interfere with participation or assessment (e.g., severe uncontrolled cardiovascular disease, severe pulmonary disease, significant neurological deficits affecting the lower limb). Presence of skin conditions (e.g., infection, open wounds, eczema, photosensitivity disorders) in the area designated for laser treatment. Current use of anticoagulant medication (e.g., warfarin, DOACs) due to potential risk, unless stable and cleared by physician. (Consider if this is truly necessary based on HILT mechanism). History of cancer in the treatment area or active malignancy elsewhere. Known photosensitivity or use of photosensitizing medications. Pregnancy, planning pregnancy, or breastfeeding. Participation in another interventional clinical trial within the last 30 days. Inability to understand or communicate in the study language.
Where it's running
-
Faculty of Physical Therapy, Al Hayah University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Ibrahim Zoheiry, Ph.D
- Email: ibrahim.alzoheiry@hotmail.com
- Phone: 01277774949
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.